CalbaTech

CalbaTech was a life sciences company focused on the acquisition and development of early-stage biomedical technologies and products. Through its primary subsidiary, Life Science Group, the company provided specialized reagents and laboratory tools to the research community. In 2010, the company underwent a significant pivot and name change to MabCure, shifting its focus toward the development of highly specific monoclonal antibodies for the early detection and treatment of various cancers. Its historical operations were centered on building a portfolio of biotechnology assets and providing essential tools for genomic and proteomic research.